An anonymous director reports

AEQUUS ANNOUNCES STOCK OPTION GRANT

Aequus Pharmaceuticals Inc. has granted incentive stock options to employees, consultants and directors of the company for the right to purchase up to an aggregate of 645,000 common shares of the company. These stock options are exercisable at a price of 55 cents per share, for a term of eight years, and vest in tranches over a two- to five-year period. The terms of the stock options granted on Sept. 30, 2015, are in accordance with the company's stock option plan.

We seek Safe Harbor.